New Treatment Paradigms to Address R/R MM Treatment Gaps

 

Fred Hutchinson Cancer Center
A

Treatment Considerations and Best Practices for the Use of Bispecific Antibodies in R/R MM

By Fred Hutchinson Cancer Center FEATURING Andrew Cowan
By Fred Hutchinson Cancer Center FEATURING Andrew Cowan
211 views
May 26, 2023
0 Comments
Login to view comments. Click here to Login
New Treatment Paradigms to Address R/R MM Treatment Gaps
26:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Bispecifics in Multiple Myeloma

Feat. P. Mangan
14:59
Jeffrey Zonder

Managing Adverse Events of Bispecific Antibodies

30:40
MyCancerHaven

Experts Discuss Updates in Myeloma From ASCO® 2023

Feat. R. Vij, L. Costa
06:11
Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "An Outpatient Model for Teclistamab Step-U…

Feat. A. Varshavsky-Yanovsky
18:11
Fred Hutchinson Cancer Center

Linvo, Tec/Tal, & BiTEs - Oh My! Making Sense of Bispecific Anti…

Feat. R. Banerjee
06:59
ecancer

ASCO® 2023 Insights: "Teclistamab for R/R MM - Summary of Long-…

Feat. N. Van De Donk
05:22
PrecisCa

Teclistamab in R/R Multiple Myeloma: Results From the MajesTEC-1 Tri…

Feat. A. Nooka
07:25
ecancer

Updated Data From the Phase 1/2 MajesTEC-1 Study: Evaluating Teclist…

Feat. A. Nooka
05:20
Thomas Martin

Health-Related Quality of Life in R/R MM Treated With Teclistamab, a…

12:33
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Minimizing Uncertainty in Multiple Myelom…

Feat. K. Patel
14:09
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Multiple Myeloma Highlights and Clinical P…

Feat. H. Hashmi
11:54
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Betting on BCMA in Multiple Myeloma"

Feat. R. Vij
26:27
Fred Hutchinson Cancer Center

Treatment Considerations and Best Practices for the Use of Bispecifi…

Feat. A. Cowan
20:19
Total Health

Total Health MDONS 2023: Updates in Hematology

Feat. L. Mountjoy
33:17
Total Health

2023 Best of Hematology: Multiple Myeloma Updates

Feat. A. Yee
23:11
Dana-Farber Cancer Institute

Bispecific Antibodies in Multiple Myeloma

Feat. O. Nadeem
23:36
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

Immunotherapy for Multiple Myeloma

Feat. A. Cohen
22:15
Current Challenges in Hematology

Efficacy of BCMA-Targeted Therapies in Pretreated Patients With R/R …

Feat. C. Cerchione
15:14
Philippe Moreau

EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and …

18:18
Thomas Martin

State of the Art & Next Questions: MM

34:48
Kenneth Anderson

MM Cured in 2030 - What Are the Next Steps?

Feat. K. Anderson
15:08
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

New Therapies for Relapsed Myeloma in 2023

Feat. D. Vogl